Cancer is now treatable without devastating chemo side effects!
OnsozologySM vs. Oncology
Merriam Webster Dictionary defines Oncology as the study of tumors. Oncologists treat cancer, but patients experience side effects such as nausea, vomiting, diarrhea, loss of hair, appetite, and spirit.
Onsozology is a new discipline of medicine which uses chemo agents combined with a proprietary medical therapy that protects the patient from the harmful side effects of chemotherapy while still destroying cancerous cells.
“Although palliative chemotherapy is used to improve [quality of life] QOL for patients with end-stage cancer, its use did not improve [quality of life near death] QOD for patients with moderate or poor performance status and worsened QOD for patients with good performance status. The QOD in patients with end-stage cancer is not improved, and can be harmed, by chemotherapy use near death, even in patients with good performance status.” –
Oncology’s Dubious Benefits
Review of medical journals reveal that while there are some areas of achievement by chemotherapy, too often benefits are marginal or unknown. Many patients might have chosen other options had they been told the truth about the lack of meaningful benefits from conventional chemotherapy.
Non-small cell lung cancer is the leading cause of cancer deaths in the world. Lung cancer patients typically die within a year despite conventional chemotherapy.
Breast cancer is the leading cause of cancer deaths in women. A recent publication reported a 6% survival advantage for those who chose conventional chemotherapy over those who opted out, but at cost of complete hair loss and other severe toxicities.
Often colon cancer patients are told by Oncologist they have 6 months to live if they opt out of conventional therapy, but their statistics may be based upon patients not motivated to live. Colon cancer treatment protocols enable median survival of 28 months; however, patients motivated to live have been reported to live 24 months despite opting out of conventional chemotherapy.
Oncology’s Undisclosed Dubious Benefits
Review of medical journals reveal that while there are some areas of achievement by chemotherapy, too often benefits are marginal or unknown. Many patients might have chosen other options had they been told the truth about the lack of meaningful benefits from conventional chemotherapy.
Non-small cell lung cancer is the leading cause of cancer deaths in the world. Lung cancer patients typically die within a year despite conventional chemotherapy.
Breast cancer is the leading cause of cancer deaths in women. A recent publication reported a 6% survival advantage for those who chose conventional chemotherapy over those who opted out, but at cost of complete hair loss and other severe toxicities.
Often colon cancer patients are told by Oncologist they have 6 months to live if they opt out of conventional therapy, but their statistics may be based upon patients not motivated to live. Colon cancer treatment protocols enable median survival of 28 months; however, patients motivated to live have been reported to live 24 months despite opting out of conventional chemotherapy.
Oncology’s Undisclosed Dubious Benefits
"At least two thirds of people with advanced cancer in a new survey believed the chemotherapy they're receiving might cure them, even though the treatment is only being given to buy some time or make them comfortable."
How many cancer patients would undergo conventional
therapy if they were told it wouldn’t cure them or extend
their life?
A recent study (Liu et al.) showed that 86% of patients
undergoing conventional chemotherapy do so without
knowing the expected (poor) outcome. Another study
published by the Journal of Clinical Oncology reported
patients with lung cancer receiving radiotherapy that is
known to have no effect on longevity. This study concluded that “nearly 2/3 of patients are
agreeing to palliative radiotherapy with the misconception that this radiotherapy may cure their
disease.”
Oncology’s Prohibitive Costs
"Leading doctors at the Chicago 2015 American Society for Clinical Oncology railed at therapies slated to cost $1 million dollars."
The total cost of cancer drugs a few years ago was $75 billion dollars, but today exceeds $100 billion. In 2014, eleven new cancer drugs were approved by the US FDA. Although each of these new drugs costs more than $100,000 for a single course of treatment, only one extended life more than two months.
Recent immunological therapies have been hailed as a major advance for melanoma and lung cancers, but they are plagued by the fact that they induce remissions in very few patients, and each costs more than $150,000.
“Memorial Sloan Kettering Cancer Center in New York has created an interactive calculator that compares the cost of more than 50 cancer drugs with what the prices would be if they were tied to factors such as the side effects the drugs produce, and the amount of extra life they give patients.“ –
Pharmaceutical companies expend an exorbitant amount of resources to develop new drugs, but most don’t make it to market, and there are few actual breakthroughs. This may be a justification for the high prices, but their recent breakthroughs only extend life, sometimes of marginal quality, a few weeks.
Origin of Onsozology
The discipline of onsozology became possible when treatment methods were discovered that helps the body to fight cancer. A world-renown team of scientists in Berkeley developed a method of substantially reducing the side effects of chemotherapy. By using, in a strategically new way, old FDA-approved drugs which are actually antidotes to such chemo agents, these scientists figured out a way to shield patients from side effects of ordinary chemotherapy. While chemo agents are still used in this Berkeley therapy, simultaneous use of antidotes erases the reasons patients shun ordinary chemotherapy.
Onsozology uses FDA-approved antidotes to such chemo agents in a strategically new way. This new therapy protects normal dividing cells in the gastrointestinal tracts and the bone marrow from the destructive effects usually associated with chemotherapy. Higher doses of chemo agents can be used; therefore, cancer is eradicated more rapidly.
Neutrophil cells, white blood cells, routinely rid the body of ageing and sick cells to keep the body from becoming dysfunctional. Neutrophil cells are also capable of destroying damaged cancer cells that remain after chemotherapy. However, in conventional chemotherapy, neutrophil cells are decimated by chemo agents and are not able to participate in this natural immune defense. Onsozology protects the white blood cells of the bone marrow, enabling these natural immune cells to participate in killing cancer cells damaged by chemo agents.
This new approach keeps neutrophil cells circulating in the body to aid in the healing process, even after the chemo agents have left the body. Where conventional chemo may take three months to show tumor shrinkage, onsozology has achieved the same results in a month—faster remission with minimized harm to the healthy cells.
Onsozology's Holistic Approach to Cancer Treatment
Dealing with cancer is an emotional challenge and onsozology centers hire and train staff members to be sensitive to emotional issues during therapy. Patients at onsozology centers are not just subjects with blood counts and x-rays, but are whole unique individuals with feelings, dreams, and loves.
With response to conventional chemotherapy even as low as 4%, making failure and misery a common occurrence, it is difficult for oncologists to keep a smile on their faces no matter how much patients need that support. Onsozology centers provide a comprehensive approach to cancer treatment.
- Emotional Support – Center staff are hand-picked for their kindness and ability for compassion. Each staff member undergo educational workshops to ensure they provide the best emotional support. Center staff take the time to calm fears by providing essential information. Other resources are provided as needed.
- Counseling – Each center has specially trained therapists for patients and their families.
- Full Disclosure – Patients are informed of all treatment options, benefits, and possible outcomes. Each center has an Information Resource person, in addition to nurses and doctors, to aid in full understanding of the cancer treatment.
- Daily Living – Healthy eating and exercise are encouraged. Healthy, cancer-fighting foods along with consistent exercise help the body fight cancer. Diets and suggestions are supplied upon request.
Dealing with cancer is an emotional challenge and Onsozology centers hire and train staff members to be sensitive to emotional issues during therapy. Patients at Onsozology centers are not just subjects with blood counts and x-rays, but are whole unique individuals with feelings, dreams, and loves.
For treatment or questions about Onsozology, call (510) 239-8792.
Derivation of the New Term Onsozology
The word onsozology is derived from Greek words. The word SoZo, according to Thayer’s Greek Lexicon, means: “to save, to keep safe and sound, to rescue from danger or destruction; to save one from injury or peril, to save a suffering one from perishing, e.g., one suffering from disease, to make well, heal restore to health (this includes spiritual healing), to preserve one who is in danger of destruction.“ This Greek word was combined with another, On, from the Greek “onkos” which when used in the word “oncology” refers to a swelling or a tumor. As well, in Hindi, “on” means sustaining. Onsozology embraces the concept of sustained efforts towards good health rather than increasing suffering.
Although irrefutably based in Western science, developed and nurtured by advanced Berkeley team, the word onsozology is meant to convey openness to evidenced-based art and science of not only Western allopathic medicine, but classical naturopathy, chiropractic/osteopathy, and herbology. The practice of onsozology implies multi-culturalism easing adoption by diverse societies and communities of the world that practice Holistic, Eastern, and indigenous approaches to health care delivery and maintenance. With eight million cancer victims all over the world under care by all types of health practitioners, no new therapy can help people in diverse cultures without the openness of the developers.
Further research discovered Sozoexchange.com where it was stated: “Sozo is a Greek word which means to rescue or to save. It also means “creation” or “to imagine” in Japanese. Our goal is to create a global community where people are free to creatively explore, and imagine new ideas. In this community, we can all be both teachers and students as we train ourselves and our community peers. [end quote]” The notion that in onzosology, practitioners are not just teachers, and patients are not just subjects to be healed but onsozology is a practice of doctors, nurses, and patients all teaching creatively and imaginatively with each other as peers, all added impetus to introduce the new word to the world.
In order to protect the new word from deliberate misuse and obfuscation by forces economically injured by the advent of onsozology, this word should always be used with a notice of intent of registered trademarking, an SM. Trademarking is not meant to imply commercialism, because the word onsozology actually inveighs against making money from the suffering of humans.
References
Holly Prigerson et al. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life. Journal of American Medical Association Oncology. July 23, 2015.
Moshe Frankel. Refusing Treatment. The Oncologist. 18(5): 2013.
Paul Hoffman and Bob Djavan. Androgen Deprivation Therapy. Reviews in Urology. 10(4): 305- 306. 2008.
Aileen B. Chen et al. Expectation About the Effectiveness of Radiation Therapy Among Patients with Incurable Lung Cancer. Journal of Clinical Oncology. June 17, 2013.
http://www.rxlist.com/eloxatin-drug/side-effects-interactions.htm
Liu, PH et al. Physicians’ propensity to discuss prognosis is associated with patients’ awareness of prognosis for metastatic cancers. J. of Palliat.Med. 17(6):673-82. 2014.
Janine Davis and Richard Goldberg. First-line Therapeutic Strategies in Metastatic Colorectal Cancer. Oncology 22 (13): 1470-1479. 2008.
Leonard Saltz MD. At: Perspective on Value, American Society of Clinical Oncology, June 1, 2015.
Peter Loftus. How Much Should Cancer Drugs Cost? Memorial Slaon Kettering doctors create pricing calculator that weighs factors such as side effects, extra years of life. Wall Street Journal. June 8, 2015.